| PHUSE US |
2026 |
Common Issues in BIMO Clinical Site Dataset Packages |
|
source presentation source |
7 |
| PharmaSUG |
2025 |
Common Issues in BIMO Clinical Site Dataset Packages |
|
source |
9 |
| PharmaSUG |
2024 |
Guidance Beyond the SDTM Implementation Guide |
Kristin Kelly |
source |
11 |
| PHUSE US |
2024 |
Guidance Beyond the SDTM Implementation Guide |
Blue Bell |
source presentation source |
10 |
| PharmaSUG |
2023 |
'TUFF' LOVE: SDTM Pain Points Explained! |
Kristin Kelly |
source |
12 |
| PHUSE US |
2023 |
Custom Domains ... the Gaps in Standardized Data |
|
source presentation source |
8 |
| PHUSE US |
2020 |
Confusing Data Validation Rules Explained, Part 2 |
Blue Bell |
source |
6 |
| PharmaSUG |
2019 |
The Need for Therapeutic Area User Guide Implementation |
|
source |
8 |
| PHUSE US |
2019 |
The Need for Therapeutic Area User Guide Implementation |
|
source presentation source |
7 |
| PHUSE EU |
2018 |
Best Practice for Explaining Validation Results in the Study Data Reviewer's Guide |
Kristin Kelly |
source presentation source |
8 |
| PHUSE US |
2018 |
Common Define.xml File Issues Seen During FDA's JumpStart Service |
Peter Glass, Caitlin Anderson, Margo Cohen, Kathryn Matto, Austin Taylor, Sergiy Sirichenko, Max Kanevsky, Mary Doi, Alan Shapiro, Barbara Witczak, Jesse Anderson |
source poster source |
5 |
| PHUSE US |
2018 |
Confusing Data Validation Rules Explained |
|
source presentation source |
5 |
| PharmaSUG |
2018 |
Confusing Data Validation Rules Explained |
|
source |
6 |